Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...
FOX 11 Los Angeles

Dr. Oz jumps in as drug exec collapses during Oval Office press conference

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

Novo Nordisk: Hold On Tightly As The Market Tests Your Faith

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.
NJBIZ

Novo Nordisk, Eli Lilly cut GLP-1 drug costs under Medicare

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
PolitiFact

Novo Nordisk's Gordon Findlay didn't faint Nov. 6, 2025, in the Oval Office. He wasn't even there

Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House ...

Novo Nordisk: Continued Concerns Of Compounding

We sold Novo Nordisk out of the portfolio due to two concerns that made us question the company’s ability to deliver ...

Is Novo Nordisk Attractively Priced After 23% Slide Amid Industry Competition in 2025?

Wondering if Novo Nordisk shares are a bargain or overpriced? You are not alone, especially with so much buzz around healthcare leaders these days. After surging for several years, Novo Nordisk stock ...